Literature DB >> 16258727

Integrin-mediated activation of latent transforming growth factor beta.

Dean Sheppard1.   

Abstract

Members of the integrin family recognize a variety of spatially-restricted extracellular ligands. Classically, ligation of integrins activates cytoplasmic signals in the integrin-expressing cell and contributes to cell adhesion, migration, proliferation and survival. At least two members of this family, alphavbeta6 and alphavbeta8 perform an additional function, activation of latent complexes of transforming growth factor beta. In effect, this process allows integrins on one cell to activate signals on adjacent (in the case of alphavbeta6) or nearby cells (in the case of alphavbeta8). Integrin-mediated TGFbeta activation has been shown to play important roles in modulating tissue fibrosis, acute lung injury and pulmonary emphysema. Given the important roles that TGFbeta plays in modulating epithelial cell growth, epithelial-to-mesenchymal transformation and tumor invasion and metastasis, integrin-mediated TGFbeta activation is likely to play important roles in tumor growth and metastasis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16258727     DOI: 10.1007/s10555-005-5131-6

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  77 in total

1.  Pulmonary fibrosis induced by γ-herpesvirus in aged mice is associated with increased fibroblast responsiveness to transforming growth factor-β.

Authors:  Payal N Naik; Jeffrey C Horowitz; Thomas A Moore; Carol A Wilke; Galen B Toews; Bethany B Moore
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-12-21       Impact factor: 6.053

2.  Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment.

Authors:  Amir F Kagalwalla; Noorain Akhtar; Samantha A Woodruff; Bryan A Rea; Joanne C Masterson; Vincent Mukkada; Kalyan R Parashette; Jian Du; Sophie Fillon; Cheryl A Protheroe; James J Lee; Katie Amsden; Hector Melin-Aldana; Kelley E Capocelli; Glenn T Furuta; Steven J Ackerman
Journal:  J Allergy Clin Immunol       Date:  2012-04-01       Impact factor: 10.793

3.  αVβ6 integrin promotes corneal wound healing.

Authors:  José Tomás Blanco-Mezquita; Audrey E K Hutcheon; Mary Ann Stepp; James D Zieske
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-31       Impact factor: 4.799

Review 4.  Integrins as triggers of Epstein-Barr virus fusion and epithelial cell infection.

Authors:  Lindsey M Hutt-Fletcher; Liudmila S Chesnokova
Journal:  Virulence       Date:  2010 Sep-Oct       Impact factor: 5.882

5.  Epithelial cells utilize cortical actin/myosin to activate latent TGF-β through integrin α(v)β(6)-dependent physical force.

Authors:  Marilyn M Giacomini; Mark A Travis; Makoto Kudo; Dean Sheppard
Journal:  Exp Cell Res       Date:  2012-01-28       Impact factor: 3.905

6.  Activation of transforming growth factor-beta by the integrin alphavbeta8 delays epithelial wound closure.

Authors:  Claus Neurohr; Stephen L Nishimura; Dean Sheppard
Journal:  Am J Respir Cell Mol Biol       Date:  2006-03-30       Impact factor: 6.914

7.  Integrin alpha3beta1 potentiates TGFbeta-mediated induction of MMP-9 in immortalized keratinocytes.

Authors:  John M Lamar; Vandana Iyer; C Michael DiPersio
Journal:  J Invest Dermatol       Date:  2007-08-30       Impact factor: 8.551

8.  Tissue stiffness, latent TGF-beta1 activation, and mechanical signal transduction: implications for the pathogenesis and treatment of fibrosis.

Authors:  Boris Hinz
Journal:  Curr Rheumatol Rep       Date:  2009-04       Impact factor: 4.592

9.  The role of integrin alpha(v)beta (8) in neonatal hypoxic-ischemic brain injury.

Authors:  Jinhui Li; Yi Qu; Xihong Li; Deyuan Li; Fengyan Zhao; Meng Mao; Donna Ferriero; Dezhi Mu
Journal:  Neurotox Res       Date:  2009-09-23       Impact factor: 3.911

Review 10.  Defining the role of integrin alphavbeta6 in cancer.

Authors:  A Bandyopadhyay; S Raghavan
Journal:  Curr Drug Targets       Date:  2009-07       Impact factor: 3.465

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.